Please Wait
Applying Filters...
menu
    • menu
    AMI Lifesciences is Driven by Chemistry. Powered by People.

    Virtual Booth

    Contact Supplier

    Polpharma is a Polish CDMO of APIs and a significant European API producer, delivering products to companies worldwide.

    Virtual Booth

    Contact Supplier

    Bhavna Laboratories is an API & Intermediate manufacturer focusing on the muscle relaxant & ophthalmic segments.

    Virtual Booth

    Contact Supplier

    Zach System is committed to providing Highly Customized Solutions for all your Development Programs.

    Virtual Booth

    Contact Supplier

    Quotient Sciences- Molecule to Cure. Fast.

    Virtual Booth

    Contact Supplier

    pharmacompass-2-m-2025-08-25

    Virtual Booth

    An Enquiry

    Menu

    Benralizumab

    ACTIVE PHARMA INGREDIENTS

    DEVELOPMENTS

    FINISHED DOSAGE FORMULATIONS

    DIGITAL CONTENT

    GLOBAL SALES INFORMATION

    MARKET PLACE

    PATENTS & EXCLUSIVITIES

    PharmaCompass
    Xls

    Filters

    clear-filterReset all filters
    Filters Filter
    Cross PopUp
    FILTER :

    filter clear-filterReset all filters

    01 11AstraZeneca Canada Inc.

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    filter clear-filterReset all filters

    PharmaCompass
    refreshReset Filter
    refresh Reset Filter
    Price Info Price Info
    product-page Product Main Page

    01

    AstraZeneca Canada Inc.

    BENRALIZUMAB
    arrow
    iPHEX India
    Not Confirmed

    AstraZeneca Canada Inc.

    Country
    arrow
    iPHEX India
    Not Confirmed

    Patent Expiration Date : 2020-04-07

    Date Granted : 2010-09-21

    BENRALIZUMAB

    Brand Name : FASENRA

    Patent Number : 2369292

    Filing Date : 2000-04-07

    Strength per Unit : 30mg / ml

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : SUBCUTANEOUS

    Patent Expiration Date : 2020-04-07

    Date Granted : 2010-09-21

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    02

    AstraZeneca Canada Inc.

    BENRALIZUMAB
    arrow
    iPHEX India
    Not Confirmed

    AstraZeneca Canada Inc.

    Country
    arrow
    iPHEX India
    Not Confirmed

    Patent Expiration Date : 2028-05-14

    Date Granted : 2017-12-19

    BENRALIZUMAB

    Brand Name : FASENRA

    Patent Number : 2685222

    Filing Date : 2008-05-14

    Strength per Unit : 30mg / ml

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : SUBCUTANEOUS

    Patent Expiration Date : 2028-05-14

    Date Granted : 2017-12-19

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    03

    AstraZeneca Canada Inc.

    BENRALIZUMAB
    arrow
    iPHEX India
    Not Confirmed

    AstraZeneca Canada Inc.

    Country
    arrow
    iPHEX India
    Not Confirmed

    Patent Expiration Date : 2028-05-14

    Date Granted : 2020-02-25

    BENRALIZUMAB

    Brand Name : FASENRA PEN

    Patent Number : 2986531

    Filing Date : 2008-05-14

    Strength per Unit : 30mg / ml

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : SUBCUTANEOUS

    Patent Expiration Date : 2028-05-14

    Date Granted : 2020-02-25

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    04

    AstraZeneca Canada Inc.

    BENRALIZUMAB
    arrow
    iPHEX India
    Not Confirmed

    AstraZeneca Canada Inc.

    Country
    arrow
    iPHEX India
    Not Confirmed

    Patent Expiration Date : 2028-05-14

    Date Granted : 2017-12-19

    BENRALIZUMAB

    Brand Name : FASENRA PEN

    Patent Number : 2685222

    Filing Date : 2008-05-14

    Strength per Unit : 30mg / ml

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : SUBCUTANEOUS

    Patent Expiration Date : 2028-05-14

    Date Granted : 2017-12-19

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    05

    AstraZeneca Canada Inc.

    BENRALIZUMAB
    arrow
    iPHEX India
    Not Confirmed

    AstraZeneca Canada Inc.

    Country
    arrow
    iPHEX India
    Not Confirmed

    Patent Expiration Date : 2028-05-14

    Date Granted : 2020-02-25

    BENRALIZUMAB

    Brand Name : FASENRA

    Patent Number : 2986531

    Filing Date : 2008-05-14

    Strength per Unit : 30mg / ml

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : SUBCUTANEOUS

    Patent Expiration Date : 2028-05-14

    Date Granted : 2020-02-25

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    06

    AstraZeneca Canada Inc.

    BENRALIZUMAB
    arrow
    iPHEX India
    Not Confirmed

    AstraZeneca Canada Inc.

    Country
    arrow
    iPHEX India
    Not Confirmed

    Patent Expiration Date : 2034-10-23

    Date Granted : 2022-08-30

    BENRALIZUMAB

    Brand Name : FASENRA

    Patent Number : 2926089

    Filing Date : 2014-10-23

    Strength per Unit : 30mg / ml

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : SUBCUTANEOUS

    Patent Expiration Date : 2034-10-23

    Date Granted : 2022-08-30

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    07

    AstraZeneca Canada Inc.

    BENRALIZUMAB
    arrow
    iPHEX India
    Not Confirmed

    AstraZeneca Canada Inc.

    Country
    arrow
    iPHEX India
    Not Confirmed

    Patent Expiration Date : 2034-08-07

    Date Granted : 2023-05-16

    BENRALIZUMAB

    Brand Name : FASENRA

    Patent Number : 2917603

    Filing Date : 2014-08-07

    Strength per Unit : 30mg / ml

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : SUBCUTANEOUS

    Patent Expiration Date : 2034-08-07

    Date Granted : 2023-05-16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    08

    AstraZeneca Canada Inc.

    BENRALIZUMAB
    arrow
    iPHEX India
    Not Confirmed

    AstraZeneca Canada Inc.

    Country
    arrow
    iPHEX India
    Not Confirmed

    Patent Expiration Date : 2034-08-07

    Date Granted : 2023-02-28

    BENRALIZUMAB

    Brand Name : FASENRA

    Patent Number : 2918105

    Filing Date : 2014-08-07

    Strength per Unit : 30mg / ml

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : SUBCUTANEOUS

    Patent Expiration Date : 2034-08-07

    Date Granted : 2023-02-28

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    09

    AstraZeneca Canada Inc.

    BENRALIZUMAB
    arrow
    iPHEX India
    Not Confirmed

    AstraZeneca Canada Inc.

    Country
    arrow
    iPHEX India
    Not Confirmed

    Patent Expiration Date : 2034-10-23

    Date Granted : 2022-08-30

    BENRALIZUMAB

    Brand Name : FASENRA PEN

    Patent Number : 2926089

    Filing Date : 2014-10-23

    Strength per Unit : 30mg / ml

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : SUBCUTANEOUS

    Patent Expiration Date : 2034-10-23

    Date Granted : 2022-08-30

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF

    10

    AstraZeneca Canada Inc.

    BENRALIZUMAB
    arrow
    iPHEX India
    Not Confirmed

    AstraZeneca Canada Inc.

    Country
    arrow
    iPHEX India
    Not Confirmed

    Patent Expiration Date : 2034-08-07

    Date Granted : 2023-05-16

    BENRALIZUMAB

    Brand Name : FASENRA PEN

    Patent Number : 2917603

    Filing Date : 2014-08-07

    Strength per Unit : 30mg / ml

    Dosage Form : SOLUTION

    Human Or VET : Human

    Route of Administration : SUBCUTANEOUS

    Patent Expiration Date : 2034-08-07

    Date Granted : 2023-05-16

    blank

    Portfolio PDF

    Product Web Link

    Virtual Booth

    Digital Content

    Website

    Corporate PDF